23 June, 2014 by The TZ Newswire Staff Comments Off on Forget Procter & Gamble, Investors Need to Check Out Nestle
Forget Procter & Gamble, Investors Need to Check Out Nestle
Even though Procter & Gamble is often the first choice in the consumer sector, here’s why you should give credence to Nestle as well.
23 June, 2014 by The TZ Newswire Staff Comments Off on Spotting the next Chipotle: Restaurants to watch
Spotting the next Chipotle: Restaurants to watch
What’s the next big thing to pop in dining? These are the top 10 emerging brands, according to social media and online-review data.
23 June, 2014 by The TZ Newswire Staff Comments Off on Monsanto Said to Have Weighed $40 Billion Syngenta Deal
Monsanto Said to Have Weighed $40 Billion Syngenta Deal
Monsanto recently explored a takeover of $34 billion Swiss rival Syngenta in a deal that would have allowed the U.S. firm to move its tax location to Switzerland.
23 June, 2014 by The TZ Newswire Staff Comments Off on Bonus Watch ’14: RBS
Bonus Watch ’14: RBS
Royal Bank of Scotland execs are going to receive bonuses, even though the UK government owns 81 percent of the place and it has only earned a profit six out of a possible 24 times since 2008. So this is cause for excitement. Treasury is poised to approve a back-door bonus scheme at the taxpayer-owned…
23 June, 2014 by The TZ Newswire Staff Comments Off on General Electric Falls as the Dow Drops Back
General Electric Falls as the Dow Drops Back
23 June, 2014 by The TZ Newswire Staff Comments Off on The Afternoon’s Top News Headlines
The Afternoon’s Top News Headlines
23 June, 2014 by The TZ Newswire Staff Comments Off on CNBC Explains: Vertex’s cystic fibrosis drug combo
CNBC Explains: Vertex’s cystic fibrosis drug combo
A new drug combination, Kalydeco and Lumacaftor, is designed to treat many additional cases of cystic fibrosis.